日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Innovation

China breaks new ground in medical alpha isotope production

By Li Menghan | chinadaily.com.cn | Updated: 2026-03-30 11:26
Share
Share - WeChat

Alpha isotopes, often described as the "nuclear warhead against cancer", possess high-energy, short-range properties that precisely destroy cancer cells with minimal damage to healthy tissue, offering significant clinical value. However, the separation and purification of alpha isotopes present a significant technical challenge. For years, China's reliance on imports has hindered the development of its next-generation radiopharmaceuticals.

Now, the China Spallation Neutron Source — a major national scientific facility in Dongguan, Guangdong province — has overcome these production challenges by achieving mass production of three key medical alpha isotopes, with an annual output expected to treat over one million patients by 2031.

"Nearly 5 million new cancer cases are diagnosed in China each year, accounting for one-quarter of the global total, with a mortality rate exceeding 50 percent," said Wang Sheng, director of the Spallation Neutron Source Science and professor at the Institute of High Energy Physics of the Chinese Academy of Sciences.

Wang explained that once alpha isotopes enter cancer cells, the radiation they emit can break both strands of the cancer cell's DNA, causing irreversible damage. Additionally, alpha isotopes can induce a "bystander effect" by signaling molecules released from the destroyed cancer cells, which can lead to the death of nearby cancer cells that were not directly exposed to the radiation. This makes them highly valuable for targeted therapy in advanced-stage tumors.

Wang's team has broken free from the long-standing reliance on costly and unstable global supply chains. By utilizing the China Spallation Neutron Source, they harnessed excess beam current from the high-energy linear accelerator to irradiate a stacked thorium target, the raw material for isotope production.

Through a self-developed separation and purification process, scientists were able to extract three key isotopes from the hundreds of isotopic species produced. These are radium-223, actinium-225 and lead-212, which have shown excellent efficacy in treating prostate cancer and neuroendocrine tumors.

Tests confirm a radionuclide purity exceeding 99 percent, with quality comparable to imported ones and marking a successful multipurpose application of the major national scientific facility.

"Compared with traditional nuclear reactors, the China Spallation Neutron Source produces alpha isotopes without relying on neutron irradiation, eliminating the proliferation risks of highly enriched uranium. It also offers flexible production capacity, broader access to raw materials, and significantly lower costs," said Professor Dai Xiongxin who is responsible for the alpha isotope industrialization project.

On Saturday, the Spallation Neutron Source Science Center signed a cooperation agreement with the China Isotope & Radiation Corporation to combine their strengths in research, development, and industrialization to accelerate the transition of China's self-developed alpha radiopharmaceuticals from laboratory research to clinical application.

Dai added that the center is advancing the construction of a dedicated alpha isotope production line to support large-scale clinical applications. Once completed, this facility will have an annual production capacity capable of supplying raw materials for nearly one million patient doses. This expansion is expected to significantly reduce costs, making these treatments more accessible and affordable for patients.

Given the short half-life of these isotopes — which makes long-distance transportation impractical — the project may foster a full-chain industry for targeted alpha therapies in Guangdong in the future, covering from raw material production, drug manufacturing to distribution, Dai added.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美日本日韩 | 久久久全国免费视频 | 成年人视频在线看 | 日韩免费观看 | h片在线免费看 | 日本精品国产 | 精品福利在线 | 成人在线精品 | 久久99在线 | 久久国内精品视频 | 一区二区三区四区在线观看视频 | 福利视频在线免费观看 | 国产一区二区三区在线观看视频 | 97av免费视频 | 亚洲精品套图 | a级网站在线观看 | 亚洲精品欧美精品 | 青青青视频在线免费观看 | 日本成人一级片 | 综合色婷婷 | 一区二区黄色片 | 国产综合影院 | 男女做爰猛烈动高潮大叫 | 国产精品111 | 国产黄频在线观看 | 久久99久久久久久久久久久 | 香蕉短视频 | 在线观看视频福利 | 国产美女啪啪 | 欧美激情国产精品 | 成人在线免费播放 | 全部免费毛片在线播放高潮 | 国产午夜三级 | 91美女福利视频 | 欲望岛av| 精品一区在线视频 | 羞羞网站在线 | 成人黄色av网站 | 都市激情中文字幕 | 亚洲在线免费观看视频 | 国产精品jizz|